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Abstract 
Access to performance-based funding from the Global Fund to fight AIDS, 
Tuberculosis and Malaria, has enabled the Western Cape Province to race 
ahead with its antiretroviral (ARV) rollout. As of 2005, The Global Fund’s 
contribution helped enable the province to provide antiretroviral treatment to 
65% of those people who desperately need it (a figure in stark contrast to the 
then South African national average of 10%). This paper illustrates how the 
Global Fund grant, in its first year, clearly met and in some cases, exceeded its 
targets particularly in relation to ARV treatment. Based on the research carried 
out as part of the preparation for this paper, it becomes clear that the Western 
Cape’s progressive and committed management team was a key contributing 
factor in successfully providing increased access to medical treatment. Other 
factors that have contributed to the success of the grant project include: the fact 
that in 1999, the province first initiated provision of ARV drugs to help prevent 
HIV-positive women transmitting the infection to their infants; and the 
experiences gained from both the introduction of treatment drugs and from the 
three-year ARV rollout projects in Khayelitsha and Gugulethu. This paper 
discusses the factors that have contributed to the success of the Western Cape 
ARV treatment programme and how, through funding from the Global Fund 
grant and other national funds, a foundation has been created for a successful 
programme. 
Introduction 
More than 40 million people worldwide are HIV-positive and since AIDS was 
first discovered, more than 25 million people have died as a result of the 
disease. Antiretroviral treatment is widely available in developed countries, 
while access to antiretrovirals (ARVs) in poorer countries has been historically 
inadequate. The World Health Organisation estimated in 2005 that out of the 6 
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million people needing life saving medication, only 1 million people are 
receiving the drugs (WHO, 2005). 
This access to life prolonging ARV treatment has caused much controversy in 
South Africa. With more than 5.2 million South Africans affected with 
HIV/AIDS, South Africa is the country with the highest number of people 
infected in the world, and AIDS is the country’s number one killer (Dorrington 
et al, 2001). The arrival of highly active antiretroviral treatment (HAART) has 
given hope to millions of people living with HIV/AIDS, however access and 
commitment from the South African government to provide the life saving 
drugs has been limited. 
The Provincial Department of Health in the Western Cape was the first to start 
providing HAART in South Africa. As funds for HAART in South Africa were 
limited, the department applied for external funding from the Global Fund to 
fight AIDS, Tuberculosis and Malaria in 2003. The proposal was successful, 
allowing the Western Cape to scale up its HAART programme. This has 
resulted in the Western Cape rollout being hailed as the ARV success story of 
the country, with more than 11 000 people living with HIV/AIDS receiving 
ARV treatment in July 2005, a quarter of whom are funded by the Global Fund.1 
It was further estimated that, at the end of 2005, 65% of those in need of ARV 
treatment in Western Cape would have access to the lifesaving drugs, a figure 
considerably higher than the South African national average of 10% (Herman, 
2006).  
This paper explores and demonstrates the success of the HAART rollout in the 
Western Cape supported and enabled by the Global Fund.  
Background: HIV/AIDS in Western Cape 
The Western Cape is one of the wealthiest provinces of South Africa’s 9 
provinces (Cummins, 2002: 49). The province has a higher per capita income 
(Statistics South Africa, 2003), the lowest HIV prevalence (see Table 1), and it 
is the province with the best success rates in the South Africa’s fight against 
HIV/AIDS (Thom, 2005). Most notably, it was the first province to introduce a 
HAART programme – which was done in collaboration with Médecins Sans 
Frontières (MSF).  
An additional contributing factor to this success is that the Western Cape health 
structure is one of, if not the best, health structures in South Africa2 and has 
                                                     
1 Keith Cloete, 30 Aug 2005, pers. comm. 
2 Gray Maartens, 4 August 2005, pers. comm. 
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remarkably high level of service3, according to MSF’s Dr Eric Goemaere: 
“The city … the level of service is amazing – like the primary health care in 
Khayelitsha compared to other provinces.”4 This has resulted in the Western 
Cape being able to provide HAART much quicker than any other province.5  
Table 1. HIV Prevalence by Province among Antenatal Clinic Attendees, 
2002 – 2004 
Province 2002 2003 2004
KwaZulu-Natal 36,5 37,5 40,7
Gauteng 31,6 29,6 33,1
Mpumalanga 28,6 32,6 30,8
Free State 28,8 30,1 29,5
Eastern Cape 23,6 27,1 28,0
North West 26,2 29,9 26,7
Limpopo 15,6 17,5 19,3
Northern Cape 15,1 16,7 17,6
Western Cape 12,4 13,1 15,4
South Africa 26,5 27,9 29,5
Source: Adapted from Department of Health (2005). 
Although the Western Cape has the lowest average HIV prevalence, this figure 
masks major differences between areas within the province. As can be seen in 
Table 2, the epidemic is concentrated in poor, predominantly African areas 
like Khayelitsha6 (PAWC, 2005a). 
Prevention of mother-to-child transmission of HIV 
The Western Cape government was the first to introduce ARVs for the 
prevention of mother-to-child-transmission (PMTCT) of HIV. As Dr Eric 
Goemeare points out, the project was introduced secretly in 1999. 
‘They had started PMTCT. They wanted to start a programme very 
low key because they didn’t want the national government to know 
                                                     
3 There are 72.4 doctors per 100 000 population and 8 000 hospital beds (Abdullah, 2005: 
246-247). These rates are higher than in any other province in South Africa (ibid). 
Around 72% of the Western Cape population depends on the public health sector for their 
health care, while the other 28% have private medical insurance (Cummins, 2002: 49). 
4 Eric Goemaere, 5 August 2005, pers. comm. 
5 John Frankish, 22 July 2005, pers. comm, Eric Goemaere; 5 August 2005, pers. comm. 
6 Khayelitsha is a poor township 30km outside of central Cape Town. It has more than 
500 000 residents with more than half of the adult population unemployed, and most 
living in informal housing (shacks). 
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about it. They had taken the initiative; the province has a lot of 
autonomy.’  (Goemaere, 2005, pers. comm., 5 Aug) 
From January 1999, PMTCT was made available to HIV-positive pregnant 
women in Khayelitsha. The Health Department of the Provincial Administration 
Western Cape (PAWC) started the PMTCT programme in two midwife 
obstetric units in Khayelitsha (Abdullah, 2005: 249).  
Table 2: HIV Prevalence by Health District, Western Cape 2000 – 2004 
District HIV Prevalence % 
  2000 2001 2002 2003 2004 
Blaauwberg  0,6 8,2 4,4 1,2
Cape Town Central  3,7 11,9 11,6 13,7
Greater Athlone  6,8 8,9 10,1 16,4
Helderberg  19,0 19,1 19,1 18,8
Khayelitsha  22,0 24,9 27,2 33
Mitchells Plain 5,4 0,7 4,0 6,3 12,9
Gugulethu/Nyanga  16,1 27,8 28,1 29,1
Oostenberg  5,7 14,5 16,1 14,8
South Peninsula  5,9 6,0 9,3 10,8
Tygerberg Eastern 5,1 6,1 10,4 7,9 12,7
Tygerberg Western  7,9 12,7 8,1 15,1
Bredasdorp/Swellendam  1,4 3,2 1,1 10
Caledon/Hermanus  13 10,8 14,4 12,5
Ceres/Tulbagh  6,2 9,4 7,5 10,5
Worcester/Robertson 3,2 5,7 4,5 3,9 8,4
Mamesbury  2,7 6,7 10,7 6,2
Paarl 4,5 8,3 11,4 10,1 8,9
Stellenbosch  7,1 8,5 8,5 17,8
Vredenburg  8,9 9,0 10,0 13
Vredendal  1,3 10,2 3,9 5,8
Knysna/Plettenberg Bay  13,3 15,9 15,6 17,4
Klein Karoo  0,8 7,8 5,4 5,5
Mossel Bay/Langeberg  7,0 6,8 13,3 12,5
George 5,6 10,0 10,0 11,6 13,3
Central Karoo  5,5 7,4 6,5 8,9
Source: Adapted from PAWC, 2005a.  
In addition to providing AZT to HIV-positive pregnant women, PAWC set up a 
voluntary counselling and testing(VCT) service at two maternity units which 
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resulted in the annual number of HIV tests being conducted in Khayelitsha 
alone to rise from 450 in 1999 to 22 000 in 2005.7  
In 1999 MSF began supporting the Khayelitsha PMTCT programme. According 
to Dr Goemare8,  MSF aimed to start a project in South Africa for three reasons:  
 Firstly, MSF was particularly interested in introducing issues around access to 
ARV treatment at the international AIDS conference, held in Durban, South 
Africa in 2000.  
• Secondly, South Africa was, according to UNAIDS, the country with the 
highest number of people living with HIV/AIDS. 
• Thirdly, MSF perceived South Africa as being the country that was 
highly devoted in the fight against drug patents.  
 
Initially MSF had considered starting a programme in Alexandra Township 
(Johannesburg). However, neither officials in Alexandra nor the national 
government were interested in a programme involving the use of ARVs. Dr Eric 
Goemaere explains how, by chance, he came to discover the PMTCT 
programme in Khayelitsha: 
‘In that time nobody suspected that there was a problem with 
antiretrovirals in this country. On the contrary there was a famous 
court case against pharmaceutical company, – to have access to 
generics. As a matter of fact, we discovered afterwards that anti-
retrovirals were never part of the fight. It was for all the types of 
contracts, the essential contracts, – it was the first time in two years 
that the anti-retroviral were not part of the national protocol. I bought 
a ticket to go back to Europe, where I was prepared to say, ‘well, 
sorry, we made a mistake’. But by chance I knew Zackie (Achmat), 
the head of TAC, by email, I had never met him, but bought a ticket 
to say hello and have a chat with him. And Zackie is the one who told 
me “you know I think they started something in Khayelitsha but I’m 
not totally sure, it looks like it’s a rumour…” so we came here, the 
next day to discover that they had started something in maternity... 
They had started PMTCT. They wanted to start a programme very 
low key because they didn’t want the national to know about it. They 
had taken the initiative; you know the province has a lot of autonomy. 
And I came that day, discovered this programme and I never left. That 
is what I’ve been doing. And that’s the reason why Khayelitsha, it’s 
                                                     
7 Eric Goemaere, 5 August 2005, pers. comm. 
8 Eric Goemaere, 5 August 2005, pers. comm. 
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the reason we came here. Since they developed the programme…’ 
(Goemaere, 2005, pers. comm., 5 Aug) 
This partnership with MSF gave PAWC the opportunity to carry out pilot 
research before applying PMTCT throughout the province. This pilot project 
was able to demonstrate that PMTCP was effective even in poor communities 
(MSF et al, 2003). The programme expanded to more than 300 antenatal and 
child health clinics in 2001(Abdullah, 2005: 249), and it has since then 
reduced mother to child  HIV transmission rates down to below 2 per cent 
for the Western Cape.9 
Pilot HAART projects  
In April 2000 the Provincial Administration of the Western Cape and MSF set 
up three clinics within Khayelitsha’s primary health care centres to provide 
PMTCT (Kasper et al., 2003). By May 2001, the HIV/AIDS clinics also began 
to offer HAART to people with an advanced stage of HIV infection.10  
The HAART project was initiated to demonstrate its feasibility in a primary 
health care setting and in a resource-limited environment. As of July 2005, the 
three clinics: Site B Khayelitsha, Site C Nolungile and Michael Mapongwana, 
provided treatment to more than 2,400 patients and accounted for almost a 
quarter of HAART patients in the Western Cape.11 In addition to providing 
HAART they also provide counselling, support, prophylaxis and treatment of 
opportunistic infections (PAWC et al, 2005). Initially the programme was almost 
exclusively run by MSF, however in the last couple of years PAWC has 
started gradually to take over12 and it is expected that the Western Cape 
will take over the clinics in 2007 (Rosenberg, 2005).  
Increased staff capacity at the three MSF clinics resulted in over 40,000 
consultations in 2004 (PAWC et al, 2005).The MSF programme was also been 
able to increase the median CD4 count of the average patient starting ARV 
treatment of 42 in 2002 (MSF et al, 2003) to 85 in 2004 (PAWC et al, 2005), 
thus indicating that patients were healthier when starting ARV treatment.  
 
                                                     
9 Ivan Toms, 23 August 2005, pers. comm. 
10 Eric Goemaere, 5 August 2005, pers. comm. 
11 Keith Cloete, 30 Aug 2005, pers. comm. 
12 Nevilene Slingers, 1 September 2005, pers. comm. 
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The next step 
Shortly after the introduction of the three MSF clinics, the Desmond Tutu 
Foundation set up a clinic in Gugulethu.13 The foundation, like MSF, carried out 
vital research for PAWC14, proving that people in limited resources 
communities could access HAART, and that they could have as high adherence 
to the ARV drugs as people in the developed countries (Orell et al, 2003).  
PAWC entered into partnerships with at least six other NGO or research-based 
initiatives in public health facilities within the Western Cape15. By the end of 
2003 the Western Cape Province had established ARV sites in Langa, at the G 
F Jooste, Groote Schuur, Tygerberg and Red Cross Hospitals in addition to the 
Gugulethu clinic and the three Khayelitsha clinics (Abdullah, 2005: 250). 
Grant SAF-304-G04-H - ‘Strengthening and 
expanding the Western Cape HIV/AIDS 
prevention, treatment and care programmes’ 
The Western Cape Department of Health has been highly committed to 
HIV/AIDS prevention, treatment and care at times when the national 
government was sceptical and unsupportive. In order to expand access to 
HAART, PAWC was forced to look for external funding. The province 
submitted its first proposal to the Global Fund to fight AIDS, Tuberculosis and 
Malaria in ‘Round Two’ but the grant was unsuccessful.16 At the time of this 
application there was massive conflict between the national government, the 
health minister, Dr Manto Tshabalala-Msimang, and the Global Fund 
Secretariat surrounding a Global Fund grant in KwaZulu-Natal. Dr Andrew 
Boulle, who was involved in writing the ‘Round Two’ application, explains 
why he thought the proposal failed to get funding: 
‘I think there were actually seventeen South African proposals in that 
round, and because the South African CCM [Country Co-ordinating 
Mechanism] didn’t follow procedure, they were all rejected on that. 
… The process was always political. The reason we all knew why 
‘Round two’ hadn’t been considered was because of the relationship 
between the South African CCM and the Fund... and I think that the 
                                                     
13 Robin Wood, 9 September 2005, pers. comm. 
14 Keith Cloete, 30 Aug 2005, pers. comm. 
15 Keith Cloete, 30 Aug 2005, pers. comm. 
16 Andrew Boulle, 10 August 2005, pers. comm. 
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Fund was very encouraging to resubmit.’ (Boulle, 2005, pers. comm., 
10 Aug). 
Dr Boulle suggests that the Western Cape knew that the proposal was rejected 
on political grounds, and on the encouragement from Dr Richard Feachem, the 
executive director of the Global Fund, they improved and resubmitted the 
proposal. Coincidently Dr Feachem was in South Africa in April 2003 to meet 
with the South African Government to solve the issue around KwaZulu Natal 
with the aim to agree on and sign the grant agreement,17 so that the programme 
could start running. Despite Dr Feachem’s hope to resolve the KwaZulu Natal 
story, the issue remained unsolved during his stay (Cullinan, 2003). By this time 
the MSF/PAWC project in Khayelitsha already was up and running, and 
according to Dr Eric Goemaere, it sparked Dr Feachem’s interest:  
‘Khayelitsha becoming a well-known programme, mainly after the 
publication by WHO, they did a sort of best practice series, and 
Khayelitsha was one of the first to be published. So Feachem was 
interested to come for a visit, and asked for a visit. So he was invited 
here and I think he was impressed by the programme and it’s very 
interesting, you know Fareed (Abdullah) used MSF against the 
national, and I’m sure Feachem used the Western Cape against 
national. It was very well known that he was going from one province 
to another. No the matter of fact, when he came to visit here he came 
to South Africa to sort out the KwaZulu Natal story … he told me that 
he thought this is a misunderstanding, let’s take a ticket – flight ticket 
and spend three days talking face to face with people, it must be, it’s 
not possible, it’s a misunderstanding and we saw Richard Feachem 
here absolutely, absolutely… he was furious. He had lost four days of 
his life for nothing – you know. In fact, he didn’t realise that South 
Africa, that it was such a mission and that he hasn’t achieved 
anything since then because it was being blocked so he was so 
pleased to find here Fareed and the whole team that was ready and 
keen to start something and he needed something that was already 
working you know.’ (Goemaere, 2005, pers. comm., 5 Aug) 
The effort of work that went into this second application was impressive; it was 
a much more inclusive and holistic proposal, involving PAWC and a number of 
NGOs. 
‘And honestly today I have never seen a public administration 
working like the way they work. I was called here 10 o’clock at night 
because they have to finalise the papers and those guys were working 
                                                     
17 Eric Goemaere, 5 August 2005, pers. comm. 
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‘til 12 o’ clock at night. I mean the public, civil servants? Not in that 
many places, and that is fantastic, you know?’ (Goemaere, 2005, pers. 
comm., 5 Aug) 
In May 2003, the Western Cape Provincial Department of Health applied for 
funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria 
(PAWC, 2003a). The application was successful and the grant was approved on 
the Global Fund’s sixth Board Meeting in Chiang Mai, Thailand, 15-17 October 
2003 (Global Fund, 2005). This initiated the grant negotiations with the 
secretariat with the final grant agreement being signed on 25 August, 2004 
(Global Fund, 2006).  The first disbursement of funds arrived on October 20, 
2004. The Western Cape Provincial Department of Health received the largest 
grant given thus far to a provincial department (PAWC, 2003b). The grant by 
the Global Fund was a five-year programme to strengthen and expand the 
province’s comprehensive HIV/AIDS programme, with a total value of the five-
year grant programme of US$66, 5 million. 
Table 3: The Global Fund Grant 
The four objectives of 







ARV Treatment / 
Operational Research 3,560,083 5,607,623 9,167,706
Peer Education 876,928 932,653 1,809,581
Palliative Care 858,857 1,586,429 2,445,286
Community-Based 
Response 866,714 1,220,069 2,086,783
Total 6,162,582 9,346,774 15,509,356
Source: Adapted from the Global Fund Work Plan, Western Cape Department of Health (2004). 
ARV drugs 
The Western Cape was fortunate to have a comparatively well functioning 
health sector, however the medical depot in Western Cape came under scrutiny 
by KPMG, (an accounting firm hired by the Global Fund) before the grant 
agreement with the Global Fund was signed.18 As a result of the changes 
demanded by KPMG, a new separate medical depot for antiretrovirals was 
setup.19 This provided a quick short-term solution to the problem, while the 
long-term solution would be to improve the existing depot.  The PAWC set up 
                                                     
18 Fareed Abdullah, 19 July 2005, pers. comm. 
19 Fareed Abdullah, 19 July 2005, pers. comm. 
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an ARV depot in six weeks, which was enough time to satisfy KPMG and get 
the grant agreement signed.20   
To this day, the ARV depot functions very well, and has never had any major 
stock shortages of ARVs.21  This could be attributed to the fact that the Western 
Cape is fortunate in having local suppliers, which enables them to purchase 
ARV drugs monthly, however the depot keeps three to four months of stock, 
which has a value of R7,5 to R10 million.22  Thus easy access to ARVs for 
clinics has insured that the sites never run out of ARVs, while the same cannot 
be said about the general medical depot. Dr Eric Goemaere, who runs the MSF 
programme in South Africa, very much appreciates the ARV depot. 
‘We have a straight management line with direct contact to one 
person to whom to decide… and if you have a problem, then Liezl 
(Channing) is available – there’s no drugs or the drug’s gone. Because 
other times you have to go via, via, via, and you don’t get an answer 
there for four weeks, that’s for sure. It makes a huge difference.’ 
(Goemaere, 2005, pers. comm., 5 Aug) 
There is no question that the specialised ARV depot has contributed to the 
success rate of the Global Fund grant. One can always criticise the solution for 
being short-term. However, the separate ARV depot has insured that ARVs are 
available at all ARV clinics at any given time, making clinics able to provide 
the life prolonging medication.  
ARV Treatment Sites 
In the grant project’s first two years, the Global Fund provided funds for ARV 
treatment sites within the metropolitan region of Cape Town. The five ARV 
sites that received Global Fund money were:  
• Gugulethu community health clinic (CHC) 
• Khayelitsha: Site B CHC 
• Khayelitsha: Site C CHC 
• Khayelitsha: Michael Mapongwana CHC 
• Masiphumelele Clinic 
All five clinics were co-run by an NGO and were all pilot research sites prior to 
the Global Fund money. This was a deliberate choice from PAWC to put the 
                                                     
20 Fareed Abdullah, 19 July 2005, pers. comm. 
21 Liezl Channing, 25 August 2005, pers. comm. 
22 Liezl Channing, 25 August 2005, pers. comm. 
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money where there was an already established programme, as they thought that 
it would assist them to build a more successful project, by up scaling as opposed 
to starting from scratch.23 Thus by choosing already well-functioning clinics 
with around 1000 people on ARV treatment, and through a planed upscale the 
Western Cape insured themselves against failure, and had perhaps the best 
foundation for a successful grant.  
Table 4. Global Fund Grant Objective 1:  ARV Treatment Year 1 
Intended results/targets in year 1  








Gugulethu 410 560 710 860 
Khayelitsha Site B 490 580 670 760 
Khayelitsha Site C 395 470 545 620 
Khayelitsha 
Michael Mapongwana 375 450 525 600 








5 sites Total 1765 2230 2695 3160 
Source: Adapted from the Global Fund Monitoring and Evaluation Plan, Western Cape Department of 
Health, (2004). 
The success of the ARV component of the grant was measured by the 
cumulative number of patients on HAART at each of the treatment sites. As 
seen in Table 4, each clinic was given specific targets. The number of patients 
starting HAART and the number of patients discontinuing treatment are also 
presented in progress reports.24  
The Five Global Fund ARV sites combined 
As a whole the Global Fund grant managed to meet or exceed its HAART 
targets. The number of new patients who started HAART with Global Fund 
money constantly performed well. Discontinuing rates, as people stop taking the 
medication, move or die, naturally affect the cumulative number of patients on 
HAART. The grant managed to hit its targets, despite some clinics performing 
just under target. For the first year of the Global Fund grant the target was to 
have 3 160 patients on ARVs at the 5 funded sites. They achieved 3 319 by the 
end of June 2005. 
                                                     
23 Fareed Abdullah, 20 July 2005, pers. comm. 




























Figure 1 Number of patients on ART at All 5 Sites  
Source: Provincial Administration of the Western Cape, Department of Health, 2005c. 
The numbers below tells how successful the grant has been in putting new 
patients on treatment in the first year of the grant. Originally the target was to 
start 1860 patients on treatment within a year, but in fact 2216 were started, a 
number which clearly exceeds the target.   

























































Figure 2 Number started on treatment at 5 global Fund Sites  
Source: Provincial Administration of the Western Cape, Department of Health, 2005c. 
In the first year, 334 patients discontinued HAART. Despite this, the grant still 
exceeded its targets, both when it came to new HAART patients as well as total 
number of people on treatment. 
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The general rollout in Western Cape 
The Western Cape has been hailed as the ARV success story in South Africa as 
it has been able to provide HAART to HIV-positive persons faster than any 
other province. The well-run pilot projects gave the province something to 
build on. Following the South African National Cabinet’s decision of 19 
November 2003 to implement and fund a national HAART programme, and 
along with the promised grant from the Global Fund, the HAART  rollout 
began gradually in 2004.25 The Western Cape was, as of December 2005, 
reaching an estimated 65% of those in need of ARV treatment in the province 
(F. Abdullah cited in Herman, 2006). This figure coincides with the ASSA 
AIDS model, which PAWC has used when planning for the needs of ARV 
treatment.26  However, nationally, it was estimated that only 10% of those in 
need of treatment had access to ARV treatment in 2005 (F. Abdullah cited in 
Herman, 2006). Thus illustrating, quite clearly the success of the Western Cape. 
Other urban areas like Johannesburg and Pretoria have had a slower start, but 
have since caught up in total numbers.27   
The Western Cape’s five Global Fund sites were a part of the 44 planned ARV 
sites by March 2006. In August 2005 there were 39 ARV sites operational, and 
as of end of July 2005 there were 10 451 people on treatment.28 The Western 
Cape has performed well, by exceeding their own target of 10 000 people on 
treatment by December 2005 and reaching the target in July 2005. In August 
2005 the programme enrolled an average of 800 new HAART patients 
monthly.29 
Dr Gary Maartens has compared the HAART rollout in Western Cape to a 
‘military operation’.30 PAWC has, accordingly to Dr Keith Cloete, the 
HIV/AIDS director in PAWC, followed a very detailed and well-planned 
structure: 
‘It eventually became a detailed month per month plan, which you 
can equate to a kind of military operation because it got to that level 
of detail and we roughly stuck to all those targets…’ (Cloete, 2005, 
pers. comm., 30 Aug)  
                                                     
25 Keith Cloete, 30 Aug 2005, pers. comm. 
26 Fareed Abdullah, 23 Sept 2005, pers. comm. 
27 Keith Cloete, 30 Aug 2005, pers. comm. 
28 Keith Cloete, 30 Aug 2005, pers. comm. 
29 Keith Cloete, 30 Aug 2005, pers. comm. 
30 Gray Maartens, 4 August 2005, pers. comm. 
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PAWC had a good working knowledge of operational issues having 
experience in working with ARVs, both in the PMTCT programme and the 
pilot HAART sites. On the basis of the experiences from the pilot projects, 
Western Cape developed a strategy for the antiretroviral rollout.31The decision 
on where to place the HAART sites was based on a combination of 
geographical access and high HIV prevalence areas.32  
Critical Success factors  
The Western Cape Global Fund grant has been highly successful in meeting the 
targets set. The overall rollout of HAART in the Western Cape has also been 
described as a success.  
The Western Cape had several advantages, relative to other provinces, that 
enabled them to progress faster than other provinces with regard to HAART. 
Firstly the province had a pre-existing good health structure and system with 
tertiary hospitals, mobile clinics and district and community clinics. Secondly, 
the province is predominantly urban, with the majority of the population living 
in and around Cape Town. Thus it was easier to focus on a fewer number of 
clinics. Thirdly, Western Cape had the lowest HIV prevalence rate in South 
Africa, thus the infection rates were lower, and thus more manageable. 
Fourthly, Western Cape was fortunate in being able to attract committed health 
professionals as Cape Town is known to be a beautiful city where people would 
like to live.  
Other factors that contributed to this success are discussed below.  
Timing   
Timing played a crucial role in the success, as the Western Cape was fortunate 
to obtain a partnership with MSF in Khayelitsha at a time when national policy 
was opposed to the use of ARVs, both in pregnant women, children and adults.  
If MSF had not arrived in Cape Town, it would have taken Western Cape a 
much longer time to develop the expertise that MSF acquired in Khayelitsha, 
and hence the Global Fund programme and the general rollout would not have 
these advantages, and thus the programme might not have been successful.  
Timing also played a vital role in the arrival of the Global Fund grant. The grant 
coincided with the national rollout. This allowed the Western Cape to use the 
                                                     
31 Fareed Abdullah, 20 July 2005, pers. comm, Keith Cloete, 30 Aug 2005, pers. comm. 
32 Keith Cloete, 30 Aug 2005, pers. comm. 
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Global Fund money to expand the rollout to reach more areas than they would 
have reached without the grant money. The provincial administration could 
make the Global Fund five sites part of the bigger rollout plan which involved a 
planned 44 sites. 
Had the Global Fund grant been approved in round two, and not in round three, 
then the grant would most likely have arrived at a time when the South African 
national government was opposed to free ARVs through the public health 
system. This would probably have made it more difficult to achieve success 
with the programme and would most likely of raised more controversy around 
the topic.  
Experience through partnerships 
A key to the success of both the Global Fund supported HAART programme 
and the general rollout of HAART in the Western Cape can be attributed to the 
successful partnerships between PAWC and independent organisations. The two 
partnerships that have been extremely important for the success of the Global 
Fund grant are the Médicins Sans Frontières (Khayelitsha) and the Desmond 
Tutu HIV Centre (Gugulethu). 
These two partnerships were particularly vital in the early days of the rollout 
when national policies were against public HAART programmes. These 
organisations produced vital research on how to provide HAART in resource-
poor environments, proving that adherence to the drugs was as good as in 
developing countries.33 
The partnerships, especially the MSF partnership on PMTCP of HIV, which 
started in 1999, gave the Western Cape Department of Health an opportunity to 
gain vital experience in managing ARVs in a resource poor communities while 
the national debate was raging. This has been categorised as a smart move by 
the provincial administration. 
‘Fareed (Abdullah) was clever enough putting this totally as private 
research, but in fact in governmental site. So in fact, in a way he 
protected himself from the rage of national. So he could always claim 
“oh, no it is not us” But at the same time he could benefit from the 
experience.’ (Goemaere, 2005, pers. comm., 5 Aug) 
Although antiretrovirals were available in the private health sector at the 
time, PAWC had limited experience with implementing and managing ARV 
                                                     
33 See Coetzee et al. (2005), Coetzee et al. (2004), Kasper et al. (2003), Orrell et al. (2003). 
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treatment, and it would be a fair comment to say that they would not have been 
able to gain the same level of experience without the MSF partnership in 
Khayelitsha. 
‘And MSF has helped. Great help of course… I mean the Khayelitsha 
pilot and showing that it worked and dealing with all the problems… 
and MSF involvement in Khayelitsha… putting out papers and things 
that showed that they were able to keep the compliance and all that so 
it wasn’t as dangerous for people to worry about, has also 
strengthened our hand at an early stage.’ (Toms, 2005, pers. comm., 
23 Aug) 
‘I think they would have been able to have significant pilot sites 
operational, but not to the scale. Not as early as 2000/2001, not at the 
scale of Khayelitsha, and not in Khayelitsha, because I mean the MSF 
involvement was the key to starting a lot earlier before any other 
organisations got going a bit later when more funding became 
available etc. I think Khayelitsha as a surface context was a very 
challenging surface context... and not many other NGOs would have 
chosen to start there… and I think having a partner with a strong 
political and advocacy vision was important at the time, given the 
political context.’ (Boulle, 2005, pers. comm., 10 Aug) 
When the pilot sites initiated ARV treatment both in Khayelitsha and in 
Gugulethu, PAWC was able to gain uniquely different experiences, from two 
different communities with high HIV prevalences. Khayelitsha is a more mobile 
community, with great influx of patients from Eastern Cape, while Gugulethu is 
a much more stable community.34 The two projects also operated with different 
counselling models thus potentially providing insight into which models work 
the best in terms of encouraging adherence.  As of July 2005 PAWC had not 
decided which model provided the best result.35  
From 2000/2001 the Western Cape developed other partnerships with regard to 
the provision of HAART. The partnership with the organisation ‘Kidzpositive’ 
at the Groote Schuur Hospital in Cape Town provided vital insight into 
paediatric HAART (Abdullah, 2005). Since 2003, PAWC has had a strong 
partnership with ‘Absolute Return for Kids’ (ARK), a non-governmental 
organisation. ARK helped with the scale up of new HAART sites by bringing 
in a team of doctors, nurses and/or pharmacists rapidly to improve capacity 
                                                     
34 Nevilene Slingers, 1 September 2005, pers. comm. 
35 John Frankish, 22 July 2005, pers. comm. 
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at the site.36 This happened at many of the HAART sites, however not at the 
five sites funded by the Global Fund.  
The pilot projects in 2000 represented the starting point of HAART provision 
in Western Cape. The later general rollout, in 2004, started with the pilot 
sites then gradually expanded to other sites. The four Global Fund sites, 
which were previous pilot sites, were extended and scaled up access to 
HAART. The fifth site, the Masiphumelele site in Fish Hoek, Cape Town, 
was set up in late 2004 with the knowledge gained from the pilot project in 
Gugulethu (Wood, 2005, pers. comm., 9 Sept).  
For the Western Cape, partnerships have been an essential component in the 
fight against AIDS. By creating partnerships the province was able to expand 
their projects and gain more knowledge than they would have done without 
the partnerships. The early experience with HAART provision in poor 
communities in Khayelitsha and Gugulethu gave the Western Cape an 
advantage over other provinces. This was, according to Dr Fareed Abdullah37, 
the main reasons for the quick scale up and early success.38 
Involvement of civil society 
The provincial administration in the Western Cape has a strong partnership 
with civil society39, particularly the Treatment Action Campaign (TAC). TAC 
promotes patient advocacy and community involvement with most of the urban 
HAART sites. This has been clearly demonstrated in Khayelitsha where HIV 
services were developed alongside strong civil society pressure and 
community-based education programmes. 
‘I mean the main success factor is the involvement of TAC, we came 
with a technique – a technical proposal, its possible to treat HIV … 
So TAC has been very useful here, in by the way; TAC and MSF 
developed together here in Khayelitsha. When we arrived they were at 
an office in town, they were a few, a few people that formed the 
community-based community rooted TAC – they come from all sorts 
of places, some they decide to disclose and that’s something useful 
for the treatment of the people so that is an enormous factor.’  
(Goemaere, 2005, pers. comm., 5 Aug) 
                                                     
36 Keith Cloete, 30 Aug 2005, pers. comm. 
37 Dr Abdullah was until January 13 2006 the Western Cape Deputy Director General: 
District Health.  
38 Fareed Abdullah, 19 July 2005, pers. comm. 
39 Keith Cloete, 30 Aug 2005, pers. comm. 
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The TAC acted on a provincial and national level, mobilising the community, 
making HIV/AIDS and access to HAART a political issue.40 TAC has 
educated many people in the community about HIV/AIDS, prevention and 
ARV therapy ("treatment literacy"). In Khayelitsha, TAC's Project Ulwazi 
("knowledge") used HIV-positive people to educate the community, with the 
goal of promoting disclosure and reducing stigma (MSF et al, 2003).  
‘The Treatment Action Campaign brings with it a completely 
different dimension in terms of their partnership. It was more a 
partnership of encouraging people on the ground to engage in the 
treatment programme and doing a lot of mobilisation in communities 
where the treatment is needed, and doing a lot of treatment literacy 
and a lot of things that kind of combat stigma with an exceptional 
groundwork in terms of making the Western Cape a fertile ground for 
a good roll out programme. So that it’s dealt with a lot of programmes 
that we would never be able to cope with or begin to deal with if we 
had to do it in absence of that partnership.’ (Cloete, 2005, pers. 
comm., 30 Aug) 
Although difficult to prove, TAC’s involvement in Khayelitsha, in combination 
with MSF and the provincial administration in the Western Cape might have 
created more openness and knowledge around HIV and AIDS, and possibly 
reduced stigma. More people in Khayelitsha were willing to take HIV tests to 
determine their status than in any other community; 60% of women aged 20-24 
years took an HIV test (Eric Goemaere quoted in Rosenberg, 2005).  In South 
Africa, generally, it is believed that the vast majority of people do not know 
their HIV status.  No other community in South Africa can show such high 
results with regard to willingness to take HIV tests as Khayelitsha (ibid). This 
indicates that there might be more openness around HIV/AIDS in Khayelitsha 
relative to other areas.  
‘Ok. TAC… you know that’s a good one. I think in Khayelitsha 
they’ve been particularly good, hey… and I mean just overall they’re 
good. But in Khayelitsha they’ve been particularly good. And how I 
think they’ve helped amazed me. You see I don’t think we’ve had to 
use… where in a sense nationally TAC has had to be in a sense on the 
attack to try and force government to do things. Here in the Western 
Cape, TAC and Fareed (Abdullah) are particularly very close you 
know… and they’ve been able to affirm what we’ve been doing rather 
                                                     
40 TAC has been on the forefront demanding access to treatment. They have, among other 
things, taken the health minister to court for not allowing HIV-positive women to be treated 
with ARVs so that the babies would have a reduced risk of transmission. For more 
information on TAC see www.tac.org. 
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than attack it, and I think that’s a better relationship and so they’ve 
been able to put their energies into helping people understand the 
treatment, understand what the drugs are, understand sort of the 
potential fall-outs and things like that why they shouldn’t… So I 
mean a young client in Khayelitsha on antiretrovirals probably knows 
more about the drugs and the side effects and all that than I do, just 
about… I mean they’re amazingly informed.’ (Toms, 2005, pers. 
comm., 23 Aug) 
According to Coetzee and Nattrass (2004:4), patients in Khayelitsha were also 
more open and willing to disclose their HIV status, having found that 72.6% 
had disclosed to a support group, while 82% had disclosed to one or more 
family member. Goemare supports this and believes that the stigma attached to 
HIV/AIDS has declined drastically since 1999.41   
In addition to TAC, many other organisations have been active in the fight 
against HIV/AIDS. Academic institutions and researchers have also been 
involved in discussions on ARV treatment.42 The combination of all these 
initiatives has helped to create a united environment in Western Cape promoting 
openness around HIV/AIDS. 
Synergy 
The united environment around HIV/AIDS in Western Cape created by the 
involvement of civil society created openness and unity. The pilot projects and 
the partnerships made people think that there was a will to do something in 
the Western Cape. The provincial HIV/AIDS administration in the Western 
Cape was viewed as credible; they were doing all they could, in light of the 
national policies, to expand access to HAART. All actors in the fight against 
AIDS were in agreement. There were no disparities and controversies like at 
the national level.  
There was also a strong connection and between the three leading 
institutions/organisations via the three leading men; Fareed Abdullah (PAWC), 
Zackie Achmat (TAC) and Eric Goemaere (MSF), in the fight against AIDS. 
This naturally eased tension, and helped create synergy. 
‘Here in the Western Cape, TAC and Fareed (Abdullah) are 
particularly very close…’  (Toms, 2005, pers. comm., 23 Aug) 
                                                     
41 Eric Goemaere, 5 August 2005, pers. comm. 
42 Gray Maartens, 4 August 2005, pers. comm. 
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Dr Eric Goemare on his relations with Dr Fareed Abdullah:  
‘Excellent - from the beginning; very fruitful. I mean I’ve been doing 
this work for MSF for more than 30 years and it’s definitely the best 
relation I have ever had. With national it is probably the worst I have 
had.’ (Goemeare, 2005, pers. comm., 5 Aug) 
‘I think the word for me would be “synergy”, particularly with 
Khayelitsha. TAC, province, city… um, youth centres, NGO’s 
involved, MSF, you know… you’ve got this synergy going, they 
really and they work together, they think together, they understand 
each other, they’re a team.’ (Toms, 2005, pers. comm., 23 Aug) 
Leadership/Management 
The decision to involve civil society and establish partnerships was taken by the 
HIV/AIDS management team, led by Deputy Director Dr Fareed Abdullah. In 
this research the management style of the HIV/AIDS team in Western Cape has 
come out as an important factor in the success of the HAART programme. 
Almost all interviewed, in the research process, acknowledged the 
importance of Dr Fareed Abdullah’s leadership and his team’s well-
functioning management style. Several visualised how well the Western Cape 
functioned in comparison to the neighbouring province of the Eastern Cape, 
where things run much less smoothly.  
For any programme to be successful you need good management and well 
functioning systems in place. This is particularly important in the context of the 
Global Fund. The Global Fund requires progress reports and the Local Fund 
Agent assesses the grant performance, making monitoring and evaluation a 
crucial part of grant management. If a grant is not performing well, and not 
reaching its targets, or if it is not accountable, then the grant faces the risk of 
termination. This has recently been seen with the Global Fund grant to loveLife 
in South Africa. LoveLife applied for ‘phase two’ funding, however the 
application was declined. This resulted in loveLife loosing one third of its 
funding, which naturally has adverse implications on their project. The grant 
given to Western Cape will also face termination if not performing well, thus 
good management to meet targets could be vital.  
In the Western Cape, Dr Fareed Abdullah was in charge of the HIV/AIDS team, 
which is also the unit that is responsible for the Global Fund grant (Global 
Fund, 2006). The implementation and management of the Global Fund grant 
had been carried out within existing programmes in the provincial 
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administration in Western Cape43, and parallel systems and structures, apart 
from the special ARV depot, have not been developed.44 Even though the 
existing management personnel, structures and systems have managed and 
implement the Global Fund grant, only a handful of additional personnel were 
appointed in the first year of the grant to coordinate the Global Fund aspects of 
the already existing programmes.45 
All involved in the administrating and managing the Global Fund grant met 
monthly to discuss the progress of the grant.46 These meetings created peer 
pressure with regards to performance, making the responsibilities more focused 
on meeting targets.47 Thus this management and infrastructural supporting 
frameworks can be attributable to the successful management and meeting of 
targets for the Grants. 
‘It’s almost the perfect example. I’ve never seen such a good example 
of funding that instead of making people dependent, stimulate their 
ambition.’ (Goemaere, 2005, pers. comm., 5 Aug) 
‘I think we’ve got a very good team spirit … dealing with the Global 
Fund was actually quite a good team-building exercise.’ (Cloete, 
2005, pers. comm., 30 Aug) 
Dr Fareed Abdullah has been responsible for the Western Cape’s AIDS 
programme since 1995 (Herman, 2006) and in 1999 he had the courage and 
dedication to start the first PMTCT programme in South Africa. Abdullah also 
had the foresight to sign an agreement with MSF to do pilot research on 
HAART.48 
‘It was a political risk…The management style was fantastic’ 
(Maartens, 2005, pers. comm., 4 Aug) 
‘There were these huge tensions with the national minister and she 
was saying that AZT was poison…’ (Toms, 2005, pers. comm., 23 
Aug) 
It takes a strong leadership to go against national policies, it takes a visionary to 
unite the province and it takes charisma and motivation to attract a good 
management team. During interviews, these were the types of qualities ascribed 
                                                     
43 John Frankish, 22 July 2005, pers. comm. 
44 Fareed Abdullah, 19 July 2005, pers. comm. 
45 John Frankish, 22 July 2005, pers. comm. 
46 Fareed Abdullah, 19 July 2005, pers. comm. 
47 Pren Naidoo, 1 August 2005, pers. comm. 
48 Eric Goemaere, 5 August 2005, pers. comm. 
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to Dr Fareed Abdullah. Many have attributed the success of AIDS treatment in 
the Western Cape to a large extent to Dr Abdullah’s drive and commitment.  
‘I think a huge amount of that must go to Fareed’s (Abdullah) drive 
and commitment…  That I fully take my hat off for what he’s done in 
terms of that and be able to put together that Global Funding 
document and make it really work…  That’s brilliant.’ (Toms, 2005, 
pers. comm., 23 Aug) 
‘Fareed (Abdullah) is also a very strong leader and a good visionary. 
He always challenges you, but supports you to the goal... like he he‘ll 
say “We are going to do this…” and we’ll all look at each other and 
think oh how are we going to do this? I don’t know if it is his 
charisma or what it is, but somehow he inspires us to get there and he 
supports us through the process as well which has been great. I think 
he is also one of our KEY success factors.’ (Channing, 2005, pers. 
comm., 25 Aug)  
Dr Abdullah also had the vision to apply for funding from the Global Fund 
despite the controversies in KwaZulu-Natal. When MSF’s Dr Eric Goemaere 
was asked “could it have been done without him?” he replied: 
‘I’m not sure. It’s a good question, and relevant question. I’m not 
sure… his skills, his style; he is very good in creating a team. He 
managed to create a management team – Have you see a management 
team like that at national level? It is a big job and he has charisma, 
vision, he sees far, and that makes a big difference I think.’ 
(Goemaere, 2005, pers. comm., 5 Aug) 
‘I think that Fareed is quite lucky and fussy in terms of the fact that he 
tends to chose hand picked people that he involves in his team… He 
is clearly a very committed person… He is very honest and respects 
whatever you say… He chooses people who are highly motivated, 
who can get the job done, and who have done well and shown that 
they can do well in difficult circumstances. Those are the people that 
he has pulled into the team.’ (Slingers, 2005, pers. comm., 1 Sept) 
‘I think one of the things that Fareed did, in his wisdom did bring a 
pharmacist into programme, which never happened before. So very 
often I would sit in meetings and they will be planning things, 
planning changes and obviously a pharmacist could see things from 
different perspectives… A clinician would say ‘we need this 
treatment’ a pharmacist might say ‘look we have this stock, it’s worth 
this amount of money and we need to get rid of it before we can…’ so 
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we just see things differently. So I think it was very good that Fareed 
brought a pharmacist into programmes in general and then 
specifically into the ARV. I form part of a core team so we have 
somebody looking after clinical, somebody looking after the site… I 
look after medicines and pharmacy related issues and I think that 
helped a lot as well.’ (Channing, 2005, pers. comm., 25 Aug)  
‘It is a very strong team.’ (Slingers, 2005, pers. comm., 1 Sept) 
Dr Fareed Abdullah was especially given credit for hiring Dr John Frankish.49 
‘We are very lucky to have John (Frankish)’ (Slingers, 2005, pers. 
comm., 1 Sept) 
‘John Frankish is no “nobody” you know, these guys manage huge 
budgets, they know about management, and of course there’s the 
whole capacity. I hear in another country is too complicated the 
Global Fund, and here its works perfectly. Again, on both sides there 
were good political reason to make sure it worked and rapidly. But it 
was sort of a dream story because of the relations with the Global 
Fund, we were helping each other in the best way to create out of it 
the best outcome we could have, and the Global Fund has stimulated 
their energy, their enthusiasm and their ambition.’(Goemaere, 2005, 
pers. comm., 5 Aug) 
It was a calculated management decision to select the five chosen Global Fund 
HAART sites.50 Starting up new ones would have demanded more work and 
would have been riskier.51 It was also calculated to keep the number of HAART 
sites in Western Cape to a low number around 40.52 Through limiting the 
number of clinics it was easier to manage the HAART supply, and to ensure 
that they were adequately staffed.53 By following this strategy the Western Cape 
made sure that they achieved their Global Fund targets and reached as many 
people in the shortest time with ARVs.54  
‘As I say it’s almost the perfect example. I’ve never seen such a good 
example of funding that instead of making people dependent 
stimulate their ambition, I mean, they could have… they could have 
sit on the global fund money and stick to that but they say ok, we can 
                                                     
49 Andrew Boulle, 10 August 2005, pers. comm. 
50 Fareed Abdullah, 20 July 2005, pers. comm. 
51 Pren Naidoo, 1 August 2005, pers. comm. 
52 Keith Cloete, 30 Aug 2005, pers. comm. 
53 Keith Cloete, 30 Aug 2005, pers. comm. 
54 Keith Cloete, 30 Aug 2005, pers. comm. 
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get that bit and save a bit of money and do it elsewhere. So I know 
that they could have asked national well, why it works so much. No, 
no, they really pushed the roll- out - the provincial roll out as far as 
they could, save in ⅓ from the global fund to invest else where.’ 
(Goemaere, 2005, pers. comm., 5 Aug) 
Limiting the number of province- run HAART sites was a bold strategy, which 
has received a lot of criticism for only being a solution that is short-term.55 
HAART is managed by the province, it has its own medical depot, and it is 
provided in selected clinics only. The programme has not been integrated into 
the primary health care setting, as have the treatments for opportunistic diseases 
such as Tuberculosis. This could be problematic in the long run, but was 
described as a short-term necessity for the Western Cape.56  This strategy 
ensured that the PAWC reached as many HIV-positive people in need of 
HAART as fast as possible.57 And when people were dying of AIDS, it was 
important to save as many lives as possible as quickly as possible. However, the 
understanding is that after some years the HAART programme will be 
incorporated into the primary health care system, ensuring even broader 
access.58 
Potential challenges 
Key success factors such as partnership, experience, timing, management and 
synergy have all contributed to the success of the Global Fund grant in Western 
Cape. Even though the Western Cape and the Global Fund grant are seen as 
successful by many of the people interviewed for this paper, several challenges 
still remain.  
Firstly, the numbers of people who need HAART is increasing, and will keep 
increasing for the next years. This poses challenges for infrastructure and 
staffing. Clinics which operated on maximum capacity in 2005 will need to 
expand to be able to operate in 2006 and 2007. If this means that there will be 
needs such as an extra building and additional staff, these are challenges that 
have to be met by PAWC. Often building an extra facility will take a number of 
years with a slow moving bureaucracy as in the Western Cape.59 The Gugulethu 
ARV site needed a new building to be able to scale up the provision of ARVs in 
2004.60 This building was completed in 2005, and the uptake of patients rose 
                                                     
55 Eric Goemaere, 5 August 2005, pers. comm, Ivan Toms, 23 August 2005, pers. comm. 
56 Keith Cloete, 30 Aug 2005, pers. comm. 
57 Fareed Abdullah, 23 Sept 2005, pers. comm. 
58 Fareed Abdullah, 23 Sept 2005, pers. comm. 
59 Keith Cloete, 30 Aug 2005, pers. comm. 
60 Nevilene Slingers, 1 September 2005, pers. comm. 
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dramatically.  This new building was, according to Slingers (2005),61 the reason 
for the Gugulethu site meeting its Global Fund targets. The MSF in Khayelitsha 
did not possess that kind of patience and set up an extra building themselves.62 
This is well and good for the patients who need HAART in Khayelitsha, but it 
highlights a potential huge challenge for PAWC’s HAART management team.    
Secondly, medical staff, especially nurses, can be hard to find.63 Cape Town has 
been fortunate to attract medical staff to its urban clinics.64 However, challenges 
remain for the other more rural clinics. Hence PAWC has great need for the 
partnership with ARK, which helps recruit staff. Without the support from 
NGOs, once again, PAWC seems more fragile. 
Other challenges relate to issues around drug resistance, toxicity and lack of 
nutrition. The first two are medical challenges, but the last one could be a 
management issue. Key personnel in PAWC have mentioned, in interviews, that 
they underestimated the importance of nutrition, and should have included 
nutrition in the Global Fund application.65 The PAWC could then have provided 
food parcels to patients on HAART at the five Global Fund sites, which also 
happen to be placed in some of the poorest areas in Cape Town. 
Slingers (2005)66 commented that the Western Cape HAART management 
team’s success can be attributed to a focused team with a ‘can do’ spirit. She 
recalled how they approached challenges and worked hard to solve challenges. 
For example, how they phoned up doctors and nurses and personally asked 
them to come and work at a HAART site. Cloete (2005)67 further reiterated how 
a management team handles problems and challenges can say a lot about how 
well functioning the management is.  
‘One of the key success factors for me is the manner in which we 
manage challenges.’ (Cloete, 2005, pers. comm., 30 Aug) 
As the previous section shoved, the management of the ARV programme in 
Western Cape has been hailed as one of the success factors. Much credit has 
been given to the leader, Dr Fareed Abdullah and his strong management team. 
As of January 13 2006, Dr Abdullah has resigned from his position (Keeton, 
2006), leaving it to his team to follow up his successful leadership. This 
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63 John Frankish, 26 August 2005, pers. comm. 
64 Nevilene Slingers, 1 September 2005, pers. comm. 
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naturally poses a serious challenge for the future. The way the team manages 
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